|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/17 | |
| C12N 5/0783 |
| (11) | Patento numeris | 3105317 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15706399.1 |
| Europos patento paraiškos padavimo data | 2015-02-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-12-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/053162 |
| Data | 2015-02-13 |
| (87) | Numeris | WO 2015/121454 |
| Data | 2015-08-20 |
| (30) | Numeris | Data | Šalis |
| 201470076 | 2014-02-14 | DK |
| (72) |
DUCHATEAU, Philippe, FR
POIROT, Laurent, FR
|
| (73) |
Cellectis,
8, rue de la Croix Jarry, 75013 Paris,
FR
|
| (54) | CELLS FOR IMMUNOTHERAPY ENGINEERED FOR TARGETING ANTIGEN PRESENT BOTH ON IMMUNE CELLS AND PATHOLOGICAL CELLS |
| CELLS FOR IMMUNOTHERAPY ENGINEERED FOR TARGETING ANTIGEN PRESENT BOTH ON IMMUNE CELLS AND PATHOLOGICAL CELLS |